NCT05846009 A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects Status COMPLETED Phase PHASE1
NCT05845996 Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single and Repeated Doses of SAR441344 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT05844735 A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566 Status COMPLETED Phase PHASE1
NCT05844566 OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome. Status COMPLETED Phase NA
NCT05839626 A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA) Status TERMINATED Phase PHASE1
NCT05832333 Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months Status COMPLETED Phase N/A
NCT05831176 A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05819125 Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin Status TERMINATED Phase N/A
NCT05819112 A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness Status TERMINATED Phase N/A
NCT05804032 Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE3
NCT05797753 A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B) Status COMPLETED Phase PHASE1
NCT05797701 A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Absorbed by the Body, When Given Orally in Fasted Condition as a Tablet Versus as a Capsule (Part 1) and When Given Orally as a Tablet in Fasted Condition Versus as a Tablet After Food (Part 2) Status COMPLETED Phase PHASE1
NCT05796479 A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants Status COMPLETED Phase PHASE1
NCT05795907 Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT05780151 Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL) Status COMPLETED Phase PHASE4
NCT05776979 Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients Status RECRUITING Phase PHASE2
NCT05769777 Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05767346 Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM Status COMPLETED Phase PHASE3
NCT05757713 Teplizumab in Pediatric Stage 2 Type 1 Diabetes Status ACTIVE_NOT_RECRUITING Phase PHASE4